These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11153302)

  • 1. Intraoperative high-dose remifentanil in a patient on naltrexone therapy.
    Schwab CA; Wright DA
    Anaesth Intensive Care; 2000 Dec; 28(6):701-3. PubMed ID: 11153302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 3. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of EMBEda (morphine sulfate and naltrexone hydrochloride) extended-release capsules: review of postmarketing adverse events during the first year.
    Badalamenti VC; Buckley JW; Smith ET
    J Opioid Manag; 2012; 8(2):115-25. PubMed ID: 22616317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.
    Ishii K; Yamashita H; Yamaguchi M; Komatsu Y; Ryu E; Morishita S; Matsuo K; Kamada M; Ikeda T; Ashizawa K; Hara T
    Intern Med; 2020 Jan; 59(2):293-296. PubMed ID: 31534081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone: a case report of pruritus from an antipruritic.
    Sullivan JR; Watson A
    Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Remifentanil-based intraoperative anaesthesia and postoperative pain therapy. Is there an optimal treatment strategy?].
    Zöllner C; Schäfer M
    Anaesthesist; 2007 Oct; 56(10):1038-46. PubMed ID: 17762929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diverse clinical uses of opioid receptor drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-dependent error processing.
    Fellows-Smith J
    J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 12. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone-Induced Acute Opioid Withdrawal in a Stabilized Extended-Release Naltrexone-Treated Patient.
    Spitzberg AJ; Urner EM; Wirshing WC
    Prim Care Companion CNS Disord; 2020 Sep; 22(5):. PubMed ID: 32942347
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of innappropriate naltrexone use in a heroin misuser.
    Boyce SH; Armstrong PA; Stevenson J
    Emerg Med J; 2003 Jul; 20(4):381-2. PubMed ID: 12835366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintentional rapid opioid detoxification.
    Quigley MA; Boyce SH
    Emerg Med J; 2001 Nov; 18(6):494-5. PubMed ID: 11696513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute opioid withdrawal on accidental injection of naltrexone.
    Yeo M; Campbell V; Bonomo Y; Sawyer SM
    J Paediatr Child Health; 2003; 39(4):315-7. PubMed ID: 12755943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serendipitous rapid detoxification from opiates: the importance of time-dependent processes.
    Mannelli P; De Risio S; Pozzi G; Janiri L; De Giacomo M
    Addiction; 1999 Apr; 94(4):589-91. PubMed ID: 10605854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits.
    Gerra G; Ceresini S; Esposito A; Zaimovic A; Moi G; Bussandri M; Raggi MA; Molina E
    Int Clin Psychopharmacol; 2003 Sep; 18(5):261-9. PubMed ID: 12920386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.